Abstract:ABSTRACT Varicella zoster virus (VZV) reactivates from ganglionic sensory neurons to produce herpes zoster (shingles) in a unilateral dermatomal distribution, typically in the thoracic region. Reactivation not only heightens the risk of stroke and other neurological complications but also increases susceptibility to co-infections with various viral and bacterial pathogens at sites distant from the original infection. The mechanism by which VZV results in complications remote from the initial foci remains unclear. Small extracellular vesicles (sEVs) are membranous signaling structures that can deliver proteins and nucleic acids to modify the function of distal cells and tissues during normal physiological conditions. Although viruses have been documented to exploit the sEV machinery to propagate infection, the role of non-infectious sEVs released from VZV-infected neurons in viral spread and disease has not been studied. Using multi-omic approaches, we characterized the content of sEVs released from VZV-infected human sensory neurons (VZV sEVs). One viral protein was detected (immediate-early 62), as well as numerous immunosuppressive and vascular disease-associated host proteins and miRNAs that were absent in sEVs from uninfected neurons. Notably, VZV sEVs are non-infectious yet transcriptionally altered primary human cells, suppressing the antiviral type 1 interferon response and promoting neuroinvasion of a secondary pathogen in vivo . These results challenge our understanding of VZV infection, proposing that the virus may contribute to distant pathologies through non-infectious sEVs beyond the primary infection site. Furthermore, this study provides a previously undescribed immune-evasion mechanism induced by VZV that highlights the significance of non-infectious sEVs in early VZV pathogenesis. IMPORTANCE Varicella zoster virus (VZV) is a ubiquitous human virus that predominantly spreads by direct cell-cell contact and requires efficient and immediate host immune evasion strategies to spread. The mechanisms of immune evasion prior to virion entry have not been fully elucidated and represent a critical gap in our complete understanding of VZV pathogenesis. This study describes a previously unreported antiviral evasion strategy employed by VZV through the exploitation of the infected host cell’s small extracellular vesicle (sEV) machinery. These findings suggest that non-infectious VZV sEVs could travel throughout the body, affecting cells remote from the site of infection and challenging the current understanding of VZV clinical disease, which has focused on local effects and direct infection. The significance of these sEVs in early VZV pathogenesis highlights the importance of further investigating their role in viral spread and secondary disease development to reduce systemic complications following VZV infections.

Seneca Valley virus intercellular transmission mediated by exosomes

Intercellular transmission of Seneca Valley virus mediated by exosomes

Exosomes Mediate Intercellular Transmission of Porcine Reproductive and Respiratory Syndrome Virus

Exosomes secreted by CSFV-infected cells evade neutralizing antibody to activate innate immune responses and establish productive infection in recipient cells

The role of extracellular vesicles in human cytomegalovirus infection

Extracellular vesicles originating from autophagy mediate an antibody-resistant spread of classical swine fever virus in cell culture

Seneca Valley Virus 3Cpro Cleaves Heterogeneous Nuclear Ribonucleoprotein K to Facilitate Viral Replication

Seneca Valley virus 3C pro degrades heterogeneous nuclear ribonucleoprotein A1 to facilitate viral replication

Suppression of the host antiviral response by non-infectious varicella zoster virus extracellular vesicles

Experimental Seneca Valley virus infection in sows and their offspring

Pathogenicity of Seneca Valley virus in pigs and detection in Culicoides from an infected pig farm

Seneca Valley virus 3C pro antagonizes type I interferon response by targeting STAT1-STAT2-IRF9 and KPNA1 signals

Research progress on the mechanism of exosome-mediated virus infection

Exosomes mediate Coxsackievirus B3 transmission and expand the viral tropism

Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2

Seneca valley virus 3C protease blocks EphA2-Mediated mTOR activation to facilitate viral replication

Infection by Exosome-Carried Coxsackievirus B3 Induces Immune Escape Resulting in an Aggravated Pathogenesis.

Seneca Valley Virus Degrades STING via PERK and ATF6-Mediated Reticulophagy

Exosomes Facilitate Transmission of Enterovirus A71 From Human Intestinal Epithelial Cells

Exosomes cloak the virion to transmit Enterovirus 71 non-lytically

Seneca Valley Virus Attachment and Uncoating Mediated by Its Receptor Anthrax Toxin Receptor 1.